Kom-Med Labrotories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-12-2024
- Paid Up Capital ₹ 1.00 M
as on 05-12-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 M
as on 05-12-2024
- Revenue 65.61%
(FY 2022)
- Profit 50.97%
(FY 2022)
- Ebitda 121.03%
(FY 2022)
- Net Worth 36.85%
(FY 2022)
- Total Assets 225.63%
(FY 2022)
About Kom-Med Labrotories
The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.50 M.
Sradhanjali Prusty and Ankit Nayak serve as directors at the Company.
- CIN/LLPIN
U52609TG2016PTC113302
- Company No.
113302
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Kom-Med Labrotories Private Limited offer?
Kom-Med Labrotories Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Kom-Med Labrotories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sradhanjali Prusty  | Director | 07-Dec-2016 | Current |
| Ankit Nayak | Director | 01-Feb-2023 | Current |
Financial Performance of Kom-Med Labrotories.
Kom-Med Labrotories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 65.61% increase. The company also saw a substantial improvement in profitability, with a 50.97% increase in profit. The company's net worth Soared by an impressive increase of 36.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kom-Med Labrotories?
In 2021, Kom-Med Labrotories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 29 Jun 2020 | ₹1.50 M | Open |
How Many Employees Work at Kom-Med Labrotories?
Kom-Med Labrotories has a workforce of 29 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kom-Med Labrotories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kom-Med Labrotories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
